Kiniksa Pharmaceuticals International, plc Annual Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent in pure from 2017 to 2023

Taxonomy & unit
us-gaap: pure
Description
Percentage of domestic federal statutory tax rate applicable to pretax income (loss).
Summary
Kiniksa Pharmaceuticals International, plc quarterly/annual Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent history and growth rate from 2017 to 2023.
  • Kiniksa Pharmaceuticals International, plc Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent for the quarter ending June 30, 2024 was 0 pure.
  • Kiniksa Pharmaceuticals International, plc annual Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent for 2023 was 0 pure.
  • Kiniksa Pharmaceuticals International, plc annual Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent for 2022 was 0 pure.
  • Kiniksa Pharmaceuticals International, plc annual Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent for 2021 was 0 pure.
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent, Annual (pure)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 0 0 Jan 1, 2023 Dec 31, 2023 10-K 2024-02-28
2022 0 0 Jan 1, 2022 Dec 31, 2022 10-K 2024-02-28
2021 0 0 Jan 1, 2021 Dec 31, 2021 10-K 2024-02-28
2020 0 0 Jan 1, 2020 Dec 31, 2020 10-K 2023-03-02
2019 0 0 Jan 1, 2019 Dec 31, 2019 10-K 2022-02-24
2018 0 0 Jan 1, 2018 Dec 31, 2018 10-K 2021-02-25
2017 0 Jan 1, 2017 Dec 31, 2017 10-K 2019-03-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.